Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2023-06-27 2023-06-16
Drug Identification Number 02301784 02301784
Brand name TEVA-LISINOPRIL/HCTZ (TYPE Z) TEVA-LISINOPRIL/HCTZ (TYPE Z)
Common or Proper name TEVA-LISINOPRIL/HCTZ (TYPE Z) TEVA-LISINOPRIL/HCTZ (TYPE Z)
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients HYDROCHLOROTHIAZIDE LISINOPRIL HYDROCHLOROTHIAZIDE LISINOPRIL
Strength(s) 25MG 20MG 25MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C09BA C09BA
ATC description ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-16 2023-06-16
Estimated end date 2023-06-20 2023-06-20
Actual end date 2023-06-26
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments